Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Metabolic Syndrome 1Lymphoma, Non-Hodgkin 1Heart Failure 1Cardiovascular Diseases 1Cardiotoxicity 1Cardiomyopathies 1

Interventions

Echocardiography 3Electrocardiography 2Blood Specimen Collection 2ziprasidone 1Zolpidem 1Watchful Waiting 1Warfarin 1Vecuronium Bromide 1Vascular Stiffness 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Surveys and Questionnaires 1Standard of Care 1Spironolactone 1Specimen Handling 1Sevelamer 1Rocuronium 1Pulse Wave Analysis 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Lenalidomide 1Labetalol 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Heart Failure × Vascular Stiffness × Clear all
NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡